Home › Type 2 Diabetes › Texas › Lewisville
Type 2 Diabetes clinical trials in Lewisville, TX
5 studies for Type 2 Diabetes are looking for participants at sites in and around Lewisville (within about 30 miles). Open a study to see who can join and how to contact the study team.
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Epic Clinical Research, Lewisville
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
RecruitingHealthy volunteers welcome
- DC Clinical Research, Lewisville
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
RecruitingPhase 2
- Alliance Clinical - Lewisville (Epic Clinical Research), Lewisville
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
RecruitingPhase 2
- Epic Clinical Research, Lewisville
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
RecruitingPhase 2
- Alliance Clinical Lewisville (Epic Clinical Research), Lewisville
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL24 studies
- Boston, MA20 studies
- Chicago, IL19 studies
- Dallas, TX19 studies
- Miami, FL19 studies
- Columbus, OH18 studies
- Las Vegas, NV18 studies
- Atlanta, GA17 studies
- San Diego, CA17 studies
- Los Angeles, CA16 studies
Other studies in Lewisville
- Ulcerative Colitis10 studies
- Crohn's Disease9 studies
- Breast Cancer5 studies
- Inflammatory Bowel Disease4 studies
- Spinal Muscular Atrophy4 studies
- Digestive Diseases4 studies
- Metastatic Cancer3 studies
- Colorectal Cancer3 studies
- Cardiovascular Disease3 studies
- COPD3 studies
- Triple-Negative Breast Cancer3 studies
- Geographic Atrophy3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.